Technical Analysis for VRBCF - Virbac SA

Grade Last Price % Change Price Change
grade C 131.0 -13.10% -19.7500
VRBCF closed down 13.1 percent on Wednesday, February 20, 2019, on 2.15 times normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical VRBCF trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Gapped Down Weakness 0.00%

Older signals for VRBCF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Virbac SA produces and sells medicines and vaccines for companion and food-producing animals. The company offers Canigen vaccines; Clostrisan, a vaccine for the prevention of clostridiosis and botulism; Deltanil, a deltamethrin-based parasiticide for topical application; Effitix to treat tick, flea, and mosquito infestations; Epiotic, an ear cleanser; Eradia for the treatment of clostridium infections and giardiasis; and Fort Up, an injectable solution to control and treat gastro-intestinal and pulmonary parasiticides. It also provides Iverhart and Iverhart Max Soft Chew, a chewable tablets to prevent heartworm disease, as well as treat and control roundworms, hookworms, and tapeworms; Maxflor Duo/Maxflin, an antibiotic for the prevention and treatment of respiratory diseases; Milteforan, an oral treatment for canine leishmaniosis; Moxiheart, an internal parasiticide; and Multimin, a trace element injectable supplement. In addition, the company offers Nutribond to enhance dietary; Prinovox, an ectoparasiticide; Propofol, an anesthetic; Rilexine, a cephalexin-based antibiotic; Sentinel Flavor Tabs and Sentinel Spectrum, a polyvalent parasiticide tablets; Shotapen, a combination of antibiotics to treat bacterial infections; Speed Reader, a blood marker dosage analyzer; and Suprelorin, an implant to induce temporary infertility in male dogs. Further, it provides Tridectin, a parasiticide oral solution; Veterin, an antibiotic; Veterinary HPM, a petfood; and Zoletil, a multi-species general anaesthetic. Additionally, the company is involved in the production of moldings for third parties. It operates in France, rest of Europe, North America, Latin America, Asia, Pacific, and Africa and the Middle East. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Medicine RTT Medical Specialties Infectious Diseases Africa Asia Infection Antibiotics Respiratory Diseases Antibiotic Bacterial Infections Pacific Zoonoses
Is VRBCF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 150.75
52 Week Low 131.0
Average Volume 233
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 131.0000
Resistance 3 (R3) 131.0000 131.0000 131.0000
Resistance 2 (R2) 131.0000 131.0000 131.0000 131.0000
Resistance 1 (R1) 131.0000 131.0000 131.0000 131.0000 131.0000
Pivot Point 131.0000 131.0000 131.0000 131.0000 131.0000
Support 1 (S1) 131.0000 131.0000 131.0000 131.0000 131.0000
Support 2 (S2) 131.0000 131.0000 131.0000 131.0000
Support 3 (S3) 131.0000 131.0000 131.0000
Support 4 (S4) 131.0000